Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Omeros Corporation chart...

About the Company

omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.

CEO

Gregory Demopulos

Exchange

NASDAQ

Website

http://www.omeros.com

$54M

Total Revenue

243

Employees

$229M

Market Capitalization

-1.62

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $OMER News

Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade

1d ago, source:

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Hidden gems often remain undiscovered within the labyrinth of ...

Investors Profit From Avenue Therapeutics Inc (NASDAQ: ATXI) 9.29% Gain

21d ago, source:

Avenue Therapeutics Inc (NASDAQ:ATXI) traded at $0.15 at close of the session on Monday, February 26, made an upward move of 9.29% on its previous day’s price. Looking at the stock we see that its ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...